Fine Tuning: Secure Your Lab Secrets

Who was Elisha Grey? If you don't know, or aren't sure, you are not alone. Although he may have been the true inventor of the telephone, Mr. Grey has, unfortunately, been lost in anonymity at the cruel hands of fate and the patent system. Properly documenting the creative effort, securing confidential information, and acting quickly can often determine whether a scientist is heralded as a pioneer or relegated to the realm of obscure trivia, as history has done to Grey. The commercial value, viab

Written byFrank Cona
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In many countries, the first person to file for a patent is entitled to it. However, in the United States, the right to a patent is determined by who invented it first. If Mr. Grey had been able to prove he had created the first telephone, then the fact that he filed for his patent just a few hours after Mr. Bell filed would not have mattered. Whether the inventor abandons an invention or exercises due diligence in developing a working prototype also affects patent rights.

Regularly kept computer files and other reliable lab data are sources of proof, but a bound lab notebook is still the most dependable evidence in proving prior invention. The inventor must date and sign the lab book, and a witness must countersign it. Notes should be written in dark ink, so that information cannot be erased or changed. Legible handwriting is critical. The inventor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies